Back

HIV pre-exposure prophylaxis among people initiating buprenorphine for opioid use disorder: a retrospective cohort study

2025-11-27 hiv aids Title + abstract only
View on medRxiv
Show abstract

IntroductionBuprenorphine (BUP) is an effective treatment for opioid use disorder (OUD) that may create opportunities to expand access to preventive services for patients with OUD when implemented in the primary care setting. HIV prevention, particularly pre-exposure prophylaxis (PrEP), represents a vital service for persons with OUD due to HIV risk associated with injection drug use and condomless sex. Evaluating the existing integration of BUP treatment and HIV prevention is an important step ...

Predicted journal destinations